Results 171 to 180 of about 8,927 (183)

Emergence of Inflammatory Bowel Disease During Treatment With Secukinumab

Journal of Crohn's and Colitis, 2018
Reyes Serrano Giménez
exaly  

Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study

Rheumatology, 2019
J Braun, Xenofon Baraliakos, Atul Deodhar   +2 more
exaly  

Population Pharmacokinetic Modeling of Secukinumab in Patients With Moderate to Severe Psoriasis

Journal of Clinical Pharmacology, 2017
Gérard Bruin, Judit Nyirády
exaly  

Impact of Secukinumab on Endothelial Dysfunction and Other Cardiovascular Disease Parameters in Psoriasis Patients over 52 Weeks

Journal of Investigative Dermatology, 2019
Esther Von Stebut, Diamant Thaçi, Wolfgang Koenig   +2 more
exaly  

Effectiveness and safety of secukinumab in 69 patients with moderate to severe plaque psoriasis: A retrospective multicenter study

Dermatologic Therapy, 2017
Jakob Ferløv Baselius Schwensen, Robert Gniadecki, Lone Skov   +2 more
exaly  

Efficacy of the anti-IL 17 secukinumab in refractory Behçet's syndrome: A preliminary study

Journal of Autoimmunity, 2019
Gerardo Di Scala, Alessandra Bettiol, Martina Finocchi   +2 more
exaly  

Relative efficacy and safety of apremilast, secukinumab, and ustekinumab for the treatment of psoriatic arthritis

Zeitschrift Fur Rheumatologie, 2017
G G Song, Young Ho Lee, Song G G
exaly  

Severe, ulcerative, lichenoid mucositis associated with secukinumab

JAAD Case Reports, 2016
Catherine S Yang, George Kroumpouzos
exaly  

Efficacy of Secukinumab in the Treatment of Moderate to Severe Plaque Psoriasis in the North American Subgroup of Patients: Pooled Analysis of Four Phase 3 Studies

Dermatology and Therapy, 2017
David Pariser, Ronald Vender, Richard G Langley   +2 more
exaly  

Effectiveness and safety of secukinumab in Italian patients with psoriasis: an 84 week, multicenter, retrospective real-world study

Expert Opinion on Biological Therapy, 2019
Matteo Megna, Giuseppe Argenziano, Francesco Cusano   +2 more
exaly